Risk characteristics of obesity and atherosclerotic cardiovascular events in patients with schizophrenia: A single-center 10-year retrospective cohort study

Table 2 Baseline metabolic parameters and cardiovascular risk factors at our institution, n (%)/mean ± SD

Parameter	Total cohort (n = 10000)	Obese (n = 4370)	Non-obese (n = 5630)	P value
Anthropometric measures
BMI, kg/m2	29.8 ± 6.4	35.6 ± 5.2	25.3 ± 3.1	< 0.001
Waist circumference, cm	98.4 ± 16.2	110.2 ± 14.3	89.2 ± 11.4	< 0.001
Weight change from admission, kg	+18.3 ± 14.2	+28.4 ± 15.3	+10.4 ± 8.7	< 0.001
Metabolic syndrome components
Metabolic syndrome	3890 (38.9)	2543 (58.2)	1347 (23.9)	< 0.001
Hypertension	3456 (34.6)	1987 (45.5)	1469 (26.1)	< 0.001
Diabetes mellitus	1843 (18.4)	1123 (25.7)	720 (12.8)	< 0.001
Dyslipidemia	4123 (41.2)	2234 (51.1)	1889 (33.6)	< 0.001
Laboratory values
Fasting glucose, mg/dL	108.3 ± 32.4	116.7 ± 38.2	101.8 ± 26.3	< 0.001
HbA1c, %	6.1 ± 1.3	6.5 ± 1.5	5.8 ± 1.0	< 0.001
Total cholesterol, mg/dL	198.4 ± 42.3	204.3 ± 44.1	193.8 ± 40.2	< 0.001
LDL cholesterol, mg/dL	118.2 ± 35.4	122.4 ± 36.8	115.0 ± 34.0	< 0.001
HDL cholesterol, mg/dL	44.3 ± 13.2	41.2 ± 12.1	46.7 ± 13.6	< 0.001
Triglycerides, mg/dL	178.4 ± 98.3	204.3 ± 112.4	158.3 ± 82.1	< 0.001
Blood pressure
Systolic BP, mmHg	128.4 ± 18.2	132.3 ± 18.9	125.4 ± 17.1	< 0.001
Diastolic BP, mmHg	79.8 ± 11.3	82.1 ± 11.8	78.0 ± 10.6	< 0.001

HbA1c: Hemoglobin A1c; LDL: Low-density lipoprotein; HDL: High-density lipoprotein; BP: Blood pleasure.